Technology Partnerships

We work with a range of partners across a variety of sectors, all with the aim of further supporting our patients’ needs.

Catalent Logo
Cycle and Catalent

Cycle and Catalent, Inc. (NYSE: CTLT) have partnered to develop 4 products that will each use Catalent’s Zydis® oral disintegrating tablet (ODT) and Zydis Ultra® technologies.

Read the press release here.

Zydis® and Zydis Ultra® are registered trademarks of R.P. Scherer Technologies, Inc., a wholly owned subsidiary of Catalent, Inc.

GET IN TOUCH

Contact us to discuss delivering best-in-class products together to treat genetic metabolic disorders and neurological conditions.

Contact us today
ABOUT US
PIPELINE